GOVX 2.69 (-1.47%)
US3736785078BiotechnologyBiotechnology

Geovax Labs (GOVX) Stock Highlights

2.69 | -1.47%
2024-09-19 06:54:18
Geovax Labs Inc is us-based clinical-stage biotechnology company. It is engaged in developing immunotherapies and vaccines against cancers and infectious diseases using a novel patented Modified Vaccinia Ankara-Virus Like Particle (GV-MVA-VLP) vector vaccine platform. The development programs of the company focused on preventive vaccines against Human Immunodeficiency Virus (HIV), Zika Virus, hemorrhagic fever viruses, and malaria, as well as therapeutic vaccines for chronic Hepatitis B infections and cancers. The product pipeline includes HIV Preventive Vaccine, Hemorrhagic Fever Vaccines, Zika Vaccine, Malaria vaccine, and Cancer Immunotherapy.

Statistics

Range Today
2.63 2.78
Volume Today 329.2K
Range 1 Year
0.31 11.18
Volume 1 Year 485.84M
Range 3 Year
0.31 11.18
Volume 3 Year 2.81B
Range 10 Year
0.31 11.18
Volume 10 Year 3.23B

Highlights

Market Capitalization 23.82M (micro)
Floating Shares 5.24M
Current Price 2.69
Price To Earnings -0.23
Price To Revenue 50.07
Earnings Per Share -13.31
Payout Ratio 0%

Performance

Latest -1.47%
1 Month -74.26%
3 Months +97.79%
6 Months +38.66%
1 Year +417.31%
3 Years -40.75%
5 Years -28.27%
10 Years -28.27%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.